Darby Anderson Sells 733 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Darby Anderson sold 733 shares of the firm’s stock in a transaction dated Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total transaction of $78,416.34. Following the completion of the transaction, the executive vice president directly owned 46,642 shares in the company, valued at approximately $4,989,761.16. This represents a 1.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Darby Anderson also recently made the following trade(s):

• On Wednesday, February 25th, Darby Anderson sold 396 shares of Addus HomeCare stock. The stock was sold at an average price of $105.36, for a total transaction of $41,722.56.

Addus HomeCare Trading Down 3.3%

ADUS stock traded down $3.58 during midday trading on Thursday, hitting $104.02. 269,378 shares of the company’s stock were exchanged, compared to its average volume of 239,147. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $124.43. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $1.92 billion, a PE ratio of 19.97, a P/E/G ratio of 1.26 and a beta of 0.91. The business has a 50-day simple moving average of $109.57 and a two-hundred day simple moving average of $113.08.

Analysts Set New Price Targets

Several brokerages recently weighed in on ADUS. Truist Financial set a $135.00 target price on shares of Addus HomeCare and gave the stock a “buy” rating in a research note on Wednesday, January 7th. TD Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. Stephens decreased their target price on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday. BMO Capital Markets began coverage on Addus HomeCare in a research note on Thursday, November 13th. They set a “market perform” rating and a $120.00 target price for the company. Finally, Barclays reduced their price target on Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Addus HomeCare has a consensus rating of “Moderate Buy” and an average price target of $134.33.

Institutional Trading of Addus HomeCare

Large investors have recently made changes to their positions in the company. Global Retirement Partners LLC boosted its holdings in shares of Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after acquiring an additional 186 shares during the period. Larson Financial Group LLC boosted its stake in Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares during the period. Acumen Wealth Advisors LLC acquired a new position in Addus HomeCare in the fourth quarter valued at $29,000. Arax Advisory Partners raised its holdings in shares of Addus HomeCare by 95.8% in the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after buying an additional 137 shares during the last quarter. Finally, Private Trust Co. NA grew its holdings in shares of Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after buying an additional 112 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare News Roundup

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer‑term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
• Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
• Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
• Neutral Sentiment: Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
• Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. CEO insider-sale SEC filing
• Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. Short interest data

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.